V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250006937 | 250004891 | 1.6 | 70 | Curative (C) | 2014-10-26 | 2014-10-26 | RUXOLITINIB | 2 | N | 250030694 | RUXOLITINIB |
| 250006938 | 250004892 | null | null | Palliative (P) | 2013-11-03 | 2013-11-06 | RUXOLITINIB | N | null | 250030700 | ANAGRELIDE |
| 250006939 | 250004892 | null | null | Palliative (P) | 2017-09-16 | 2017-09-16 | CHOP R - 21 days | null | N | 250030700 | TRIAL |
| 250006940 | 250004892 | 1.57 | 0 | Adjuvant (A) | 2014-05-18 | 2014-06-01 | RUXOLITINIB | N | N | 250030700 | AZACITIDINE |
| 250006941 | 250004892 | 1.69 | null | Curative (C) | 2016-09-18 | 2016-09-25 | Cytarabine Low Dose | 02 | N | 250030700 | RUXOLITINIB |
| 250006942 | 250004893 | 1.69 | 75.7 | Palliative (P) | 2018-04-07 | 2018-04-07 | RUXOLITINIB | 02 | N | 250030709 | RUXOLITINIB |
| 250006943 | 250009636 | 1.64 | 64.9 | Disease modification (D) | null | 2015-03-27 | BUSULFAN | 2 | N | 250030713 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 250006944 | 250009636 | 0 | 105 | Palliative (P) | 2016-10-15 | 2016-10-15 | ANAGRELIDE | Y | N | 250030713 | RUXOLITINIB |
| 250006945 | 250009636 | null | 83.65 | Palliative (P) | 2013-06-14 | 2013-06-27 | Pemetrexed | N | N | 250030713 | RITUXIMAB |
| 250006946 | 250009636 | null | 72.2 | null | 2016-05-08 | 2016-06-06 | RUXOLITINIB | N | N | 250030713 | PEG INTERFERON |
| 250006947 | 250009636 | 0 | 61 | Disease modification (D) | 2015-03-25 | 2015-04-01 | ANAGRELIDE | N | N | 250030713 | INTERFERON |
| 250006948 | 250009636 | null | null | Palliative (P) | 2015-06-19 | 2015-06-19 | PEG INTERFERON | 02 | N | 250030713 | RUXOLITINIB |
| 250006949 | 250004894 | 1.58 | 85.1 | Disease modification (D) | 2018-07-20 | 2018-07-24 | Busulfan Oral | N | N | 250030741 | RITUXIMAB |
| 250006951 | 250004896 | 1.58 | 0 | Palliative (P) | null | 2014-08-29 | RUXOLITINIB | N | N | 250030745 | RITUXIMAB |
| 250006952 | 250004897 | 1.63 | 0 | Curative (C) | 2016-12-07 | 2016-12-07 | BORTEZOMIB + THALIDOMIDE | N | N | 250030750 | ANAGRELIDE |
| 250006953 | 250004898 | 1.6 | 0 | Disease modification (D) | 2018-02-26 | 2018-02-26 | ANAGRELIDE | 2 | N | 250030753 | RITUXIMAB |
| 250006954 | 250004899 | null | null | Palliative (P) | 2014-05-15 | 2014-05-29 | Nilotinib | N | null | 250030756 | RITUXIMAB |
| 250006955 | 250009637 | 1.81 | 100.6 | Curative (C) | 2017-03-19 | 2017-03-19 | RUXOLITINIB | 02 | N | 250030757 | RITUXIMAB |
| 250006956 | 250004900 | 1.68 | 85.1 | null | 2017-11-07 | 2017-11-07 | CVP R | 2 | null | 250030760 | RUXOLITINIB |
| 250006957 | 250004901 | 1.62 | null | Disease modification (D) | 2015-11-06 | 2015-11-06 | RUXOLITINIB | 2 | N | 250030761 | ANAGRELIDE |
| 250006958 | 250004902 | 1.75 | 74.5 | Palliative (P) | 2016-04-05 | 2016-04-05 | Trial Unspecified | N | N | 250030762 | CARBOPLATIN + VINORELBINE |
| 250006959 | 250009638 | 1.68 | 87.399 | Not known (9) | 2014-06-05 | 2014-06-06 | Imatinib 400mg | N | N | 250030767 | RUXOLITINIB |
| 250006960 | 250004903 | 1.59 | 68.1 | Disease modification (D) | 2017-03-19 | 2017-03-19 | CISPLATIN + FLUOROURACIL | N | N | 250030776 | GEMCARBO |
| 250006961 | 250004904 | 0 | 0 | Disease modification (D) | 2015-11-26 | 2015-12-02 | RUXOLITINIB | 2 | N | 250030780 | ANAGRELIDE |
| 250006962 | 250004905 | null | 0 | Palliative (P) | 2014-01-03 | 2014-01-03 | RUXOLITINIB | N | N | 250030781 | PEG INTERFERON |
| 250006963 | 250009639 | 1.72 | null | Palliative (P) | 2014-05-11 | 2014-04-29 | CVP R | 02 | null | 250030784 | ATG + BUSULFAN + FLUDARABINE |
| 250006964 | 250011581 | 1.73 | 55 | Curative (C) | 2015-03-07 | 2015-03-13 | RUXOLITINIB | 2 | N | 250030787 | FLAG + IDARUBICIN |
| 250006965 | 250012370 | 1.75 | 86.8 | Curative (C) | 2014-01-08 | 2014-01-20 | RUXOLITINIB | N | N | 250030788 | RUXOLITINIB |
| 250006966 | 250004906 | 1.47 | 88.2 | Disease modification (D) | 2013-04-29 | 2013-05-03 | INTERFERON | 02 | N | 250030789 | RUXOLITINIB |
| 250006968 | 250004908 | 0 | 94.5 | Palliative (P) | 2014-09-23 | 2014-09-23 | FEC 100 + DOCETAXEL | 02 | N | 250030794 | RUXOLITINIB |
| 250006969 | 250004909 | null | null | Curative (C) | 2015-10-01 | 2015-10-01 | AML18 PILOT TRIAL | Y | null | 250030799 | PEMETREXED |
| 250006970 | 250004909 | null | 81.3 | Palliative (P) | null | 2014-04-25 | RUXOLITINIB | N | null | 250030799 | RUXOLITINIB |
| 250006971 | 250004910 | 1.85 | 66.1 | Not known (9) | 2013-11-04 | 2013-11-04 | RUXOLITINIB | 2 | N | 250030805 | AZACITIDINE |
| 250006972 | 250004911 | 1.52 | 81.9 | Palliative (P) | 2017-08-26 | 2017-09-05 | PEG INTERFERON | N | N | 250030807 | RUXOLITINIB |
| 250006973 | 250004912 | 1.67 | 66 | Adjuvant (A) | 2015-09-25 | 2015-09-25 | ANAGRELIDE | N | N | 250030808 | RUXOLITINIB |
| 250006974 | 250004913 | null | 48.4 | Palliative (P) | 2014-08-02 | 2014-08-02 | ATG + Busulfan + Fludarabine | 02 | N | 250030809 | RUXOLITINIB |
| 250006975 | 250004914 | null | 70.3 | Palliative (P) | 2010-10-13 | 2014-07-09 | RUXOLITINIB | 2 | null | 250030813 | RUXOLITINIB |
| 250006976 | 250004915 | 0 | 71 | Disease modification (D) | 2018-05-01 | 2018-05-01 | CHOP R - 21 days | N | N | 250030817 | TRIAL |
| 250006978 | 250004917 | null | null | Disease modification (D) | 2015-06-25 | 2015-06-25 | Rituximab | 02 | N | 250030820 | RUXOLITINIB |
| 250006979 | 250009641 | 0 | 85.1 | Curative (C) | 2017-12-08 | 2017-12-31 | RUXOLITINIB | N | N | 250030824 | RUXOLITINIB |
| 250006980 | 250004918 | null | 83 | Palliative (P) | 2016-08-12 | 2016-08-19 | Capecitabine | N | N | 250030836 | PEG INTERFERON |
| 250006981 | 250004919 | 1.75 | 59.6 | Palliative (P) | 2016-11-12 | 2016-11-21 | RUXOLITINIB | 2 | N | 250030839 | ATG + BUSULFAN + FLUDARABINE |
| 250006982 | 250004920 | 0 | 0 | Palliative (P) | 2017-03-17 | 2017-03-17 | Azacitidine | Y | N | 250030840 | BENDAMUSTINE + RITUXIMAB |
| 250006983 | 250004921 | 1.56 | 0 | Adjuvant (A) | 2014-12-08 | 2014-12-08 | ANAGRELIDE | 1 | N | 250030841 | METHOTREXATE INTRATHECAL |
| 250006984 | 250004922 | 1.68 | 75 | Palliative (P) | 2015-12-26 | 2016-04-27 | RUXOLITINIB | N | null | 250030842 | RUXOLITINIB |
| 250006985 | 250004922 | 0 | 72 | Palliative (P) | 2014-07-15 | 2014-07-18 | RUXOLITINIB | N | N | 250030842 | IMATINIB |
| 250006986 | 250004923 | 1.73 | 66 | Palliative (P) | null | 2017-02-02 | RUXOLITINIB | N | N | 250030848 | RUXOLITINIB |
| 250006987 | 250004924 | 1.61 | 56 | Neo-adjuvant (N) | 2014-01-04 | 2014-01-04 | RUXOLITINIB | N | N | 250030853 | AZACITIDINE |
| 250006988 | 250004925 | null | null | null | 2016-10-15 | 2016-10-22 | RUXOLITINIB | null | N | 250030855 | RITUXIMAB |
| 250006989 | 250004926 | 1.72 | 0 | Palliative (P) | 2016-02-07 | 2016-02-19 | Azacitidine | N | N | 250030856 | DA |